Recent Advances in Site-Specific Lipid Nanoparticles for mRNA Delivery.
Journal
ACS nanoscience Au
ISSN: 2694-2496
Titre abrégé: ACS Nanosci Au
Pays: United States
ID NLM: 9918316881006676
Informations de publication
Date de publication:
21 Jun 2023
21 Jun 2023
Historique:
received:
22
12
2022
revised:
17
03
2023
accepted:
17
03
2023
medline:
26
6
2023
pubmed:
26
6
2023
entrez:
26
6
2023
Statut:
epublish
Résumé
The success of mRNA vaccines during the COVID-19 pandemic has greatly accelerated the development of mRNA therapy. mRNA is a negatively charged nucleic acid that serves as a template for protein synthesis in the ribosome. Despite its utility, the instability of mRNA requires suitable carriers for
Identifiants
pubmed: 37360845
doi: 10.1021/acsnanoscienceau.2c00062
pmc: PMC10288611
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
192-203Informations de copyright
© 2023 The Authors. Published by American Chemical Society.
Déclaration de conflit d'intérêts
The authors declare no competing financial interest.
Références
Circ Res. 2021 May 28;128(11):1766-1779
pubmed: 34043424
Adv Sci (Weinh). 2022 Dec;9(35):e2202556
pubmed: 36216580
Ann Intern Med. 2005 Mar 15;142(6):439-50
pubmed: 15767622
Nat Cell Biol. 2018 Jul;20(7):766-774
pubmed: 29950570
Nanoscale. 2019 Nov 21;11(45):21733-21739
pubmed: 31713568
Mol Ther. 2010 Jul;18(7):1357-64
pubmed: 20461061
Nat Nanotechnol. 2022 Jul;17(7):777-787
pubmed: 35551240
Nat Biomed Eng. 2021 Sep;5(9):1059-1068
pubmed: 34616046
JAMA. 2020 Aug 25;324(8):782-793
pubmed: 32648899
Science. 2000 Sep 1;289(5484):1508-14
pubmed: 10968781
Front Immunol. 2020 Mar 04;11:218
pubmed: 32194546
Immunol Rev. 2009 May;229(1):126-44
pubmed: 19426219
Pharm Res. 2022 Jan;39(1):105-114
pubmed: 35080707
Nat Biotechnol. 2022 Nov;40(11):1586-1600
pubmed: 36329321
Nat Rev Immunol. 2021 Oct;21(10):626-636
pubmed: 34373623
Nat Biomed Eng. 2020 Nov;4(11):1076-1089
pubmed: 33020600
Prim Care Respir J. 2007 Apr;16(2):71-81
pubmed: 17356785
J Clin Invest. 2008 Feb;118(2):534-44
pubmed: 18172556
Front Immunol. 2020 Dec 03;11:583084
pubmed: 33365025
Science. 2016 Jan 22;351(6271):400-3
pubmed: 26721683
Signal Transduct Target Ther. 2021 Feb 8;6(1):53
pubmed: 33558455
Mol Cell Oncol. 2014 Oct 29;1(2):e954507
pubmed: 27308323
Nat Commun. 2021 Dec 14;12(1):7264
pubmed: 34907171
Acc Chem Res. 2022 Jan 4;55(1):2-12
pubmed: 34850635
J Hepatol. 2021 Dec;75(6):1420-1433
pubmed: 34453962
Nat Rev Mater. 2021;6(12):1078-1094
pubmed: 34394960
Sci Transl Med. 2019 Dec 18;11(523):
pubmed: 31852795
J Am Chem Soc. 2022 Jun 8;144(22):9926-9937
pubmed: 35616998
Nat Nanotechnol. 2021 Jun;16(6):630-643
pubmed: 34059811
J Clin Invest. 2015 Apr;125(4):1533-44
pubmed: 25774505
Nat Commun. 2021 Dec 8;12(1):7101
pubmed: 34880218
Adv Sci (Weinh). 2023 Jan;10(3):e2205532
pubmed: 36403209
Nat Nanotechnol. 2020 Apr;15(4):313-320
pubmed: 32251383
Int J Pharm. 2013 Nov 30;457(1):50-62
pubmed: 24036012
Blood. 2005 Sep 15;106(6):2002-10
pubmed: 15941918
Science. 2022 Jan 07;375(6576):91-96
pubmed: 34990237
Nat Med. 2018 Dec;24(12):1899-1909
pubmed: 30297912
Gut. 2010 Feb;59(2):236-46
pubmed: 19671543
Environ Health Perspect. 2020 Jun;128(6):67010
pubmed: 32692251
Sci Adv. 2021 Feb 26;7(9):
pubmed: 33637537
Mol Pharm. 2022 Jun 6;19(6):1669-1686
pubmed: 35594500
N Engl J Med. 2017 Aug 31;377(9):819-828
pubmed: 28691885
Nature. 2020 Nov;587(7835):555-566
pubmed: 33239795
Eur J Cancer. 2016 Jan;52:50-66
pubmed: 26645943
Biomaterials. 2022 Sep;288:121707
pubmed: 35953326
Adv Mater. 2019 Apr;31(14):e1807748
pubmed: 30748040
Nat Rev Drug Discov. 2018 Jul;17(7):493-508
pubmed: 29880919
Cancer Discov. 2012 May;2(5):401-4
pubmed: 22588877
J Control Release. 2019 Nov 10;313:33-41
pubmed: 31634546
Adv Mater. 2022 Apr;34(16):e2201095
pubmed: 35218106
Biomater Sci. 2021 Nov 9;9(22):7534-7546
pubmed: 34647548
Adv Mater. 2021 Jun;33(23):e2007603
pubmed: 33945178
N Engl J Med. 2021 Feb 18;384(7):643-649
pubmed: 33378605
Nat Cell Biol. 2008 Jun;10(6):676-87
pubmed: 18454141
Nat Med. 2015 Feb;21(2):121-31
pubmed: 25654603
Mol Cancer. 2021 Feb 16;20(1):33
pubmed: 33593376
Nat Rev Genet. 2022 May;23(5):265-280
pubmed: 34983972
Medicina (Kaunas). 2019 Aug 23;55(9):
pubmed: 31450841
Pharm World Sci. 2000 Jun;22(3):75-81
pubmed: 11028259
Ann Hepatol. 2020 Jan - Feb;19(1):24-30
pubmed: 31548169
Nat Commun. 2018 Oct 29;9(1):4493
pubmed: 30374059
Nat Rev Immunol. 2021 Aug;21(8):475-484
pubmed: 34211186
Science. 2020 Mar 27;367(6485):1444-1448
pubmed: 32132184
Cell. 2012 Jun 8;149(6):1269-83
pubmed: 22682249
Sci Adv. 2020 Nov 18;6(47):
pubmed: 33208369
ACS Nano. 2023 Mar 14;17(5):4942-4957
pubmed: 36853930
Mol Immunol. 2014 Oct;61(2):163-73
pubmed: 25124145
ACS Nano. 2020 Dec 22;14(12):16502-16524
pubmed: 33236896
Nat Commun. 2020 Jul 13;11(1):3484
pubmed: 32661253
Nat Nanotechnol. 2019 Dec;14(12):1084-1087
pubmed: 31802031
J Blood Med. 2018 Aug 22;9:135-140
pubmed: 30174468
Proc Natl Acad Sci U S A. 2019 Oct 15;116(42):21150-21159
pubmed: 31501335
Nat Rev Gastroenterol Hepatol. 2017 May;14(5):269-278
pubmed: 28144028
Biochim Biophys Acta Rev Cancer. 2020 Jan;1873(1):188314
pubmed: 31682895
ACS Nano. 2019 Dec 24;13(12):14048-14069
pubmed: 31725257
N Engl J Med. 2020 Dec 31;383(27):2652-2664
pubmed: 33382932
Lancet Gastroenterol Hepatol. 2020 Jan;5(1):17-30
pubmed: 31648971
J Control Release. 2022 Oct;350:401-413
pubmed: 36029893
J Drug Target. 1994;2(3):241-57
pubmed: 7812693
Signal Transduct Target Ther. 2020 Jun 19;5(1):101
pubmed: 32561705
ACS Nano. 2021 Nov 23;15(11):16982-17015
pubmed: 34181394
Nat Mater. 2021 May;20(5):701-710
pubmed: 33542471
Nature. 2020 May;581(7807):215-220
pubmed: 32225176
Mucosal Immunol. 2019 Sep;12(5):1201-1211
pubmed: 31417161
Nat Med. 2022 Nov;28(11):2273-2287
pubmed: 36357682
Sci Adv. 2022 Jan 21;8(3):eabj6901
pubmed: 35061543
J Control Release. 2016 Aug 10;235:236-244
pubmed: 27238441
Expert Opin Investig Drugs. 2021 Feb;30(2):167-176
pubmed: 33393390
Adv Sci (Weinh). 2017 Sep 07;4(11):1700175
pubmed: 29201613
Proc Natl Acad Sci U S A. 2021 Dec 28;118(52):
pubmed: 34933999